VEGFA and neoplasm: Clear cell RCC commonly shows mutations in the tumor suppressor Von Hippel–Lindau gene, triggering a decrease in the degradation of hypoxia‐inducible factor, and an increase in VEGF transcription and tumor angiogenesis.5